These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3386244)
1. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies. Giambiagi N; Pasqualini JR J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244 [TBL] [Abstract][Full Text] [Related]
2. [Recognition of the activated form of estrogen receptor bound to estradiol and tamoxifen by a monoclonal antibody]. Giambiagi N; Pasqualini JR Pathol Biol (Paris); 1986 Oct; 34(8):937-42. PubMed ID: 3537937 [TBL] [Abstract][Full Text] [Related]
3. Studies on the activation of the oestrogen receptor bound to the anti-oestrogens 4-hydroxytamoxifen and ICI 164,384 by using three monoclonal antibodies. Giambiagi N; Pasqualini JR J Mol Endocrinol; 1991 Aug; 7(1):9-19. PubMed ID: 1892545 [TBL] [Abstract][Full Text] [Related]
4. Activation and immunorecognition by a monoclonal antibody of the tamoxifen-estrogen receptor complex. Giambiagi N; Pasqualini JR Biochim Biophys Acta; 1986 Oct; 883(3):559-66. PubMed ID: 3756221 [TBL] [Abstract][Full Text] [Related]
5. Immunorecognition of cytosol and nuclear estradiol receptor of fetal guinea pig uterus using monoclonal antibody. Giambiagi N; Pasqualini JR Endocrinology; 1982 Mar; 110(3):1067-9. PubMed ID: 6173208 [TBL] [Abstract][Full Text] [Related]
6. Interaction of three monoclonal antibodies with the nonactivated and activated forms of the estrogen receptor. Giambiagi N; Pasqualini JR Endocrinology; 1990 Mar; 126(3):1403-9. PubMed ID: 2307111 [TBL] [Abstract][Full Text] [Related]
7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
8. Transformation of the estrogen receptor detected by two monoclonal antibodies. Giambiagi N; Pasqualini JR J Steroid Biochem; 1989; 34(1-6):297-300. PubMed ID: 2483220 [TBL] [Abstract][Full Text] [Related]
9. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. Martin PM; Berthois Y; Jensen EV Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2533-7. PubMed ID: 2451827 [TBL] [Abstract][Full Text] [Related]
10. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Tate AC; DeSombre ER; Greene GL; Jensen EV; Jordan VC Breast Cancer Res Treat; 1983; 3(3):267-77. PubMed ID: 6671136 [TBL] [Abstract][Full Text] [Related]
11. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus. Garcia M; Greene G; Rochefort H; Jensen EV Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530 [TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody to the estrogen receptor discriminates between the nonactivated and activated estrogen- and anti-estrogen-receptor complexes. Borgna JL; Fauque J; Rochefort H Biochemistry; 1984 May; 23(10):2162-8. PubMed ID: 6733078 [TBL] [Abstract][Full Text] [Related]
13. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen. Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064 [TBL] [Abstract][Full Text] [Related]
14. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388 [TBL] [Abstract][Full Text] [Related]
15. Biological responses of tamoxifen in the fetal and newborn vagina and uterus of the guinea-pig and in the R-27 mammary cancer cell line. Pasqualini JR; Giambiagi N; Sumida C; Nguyen BL; Gelly C; Mayrand C; Lecerf F J Steroid Biochem; 1986 Jan; 24(1):99-108. PubMed ID: 3702432 [TBL] [Abstract][Full Text] [Related]
16. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction. Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013 [TBL] [Abstract][Full Text] [Related]
17. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor. Keene JL; Ruh MF; Ruh TS J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530 [TBL] [Abstract][Full Text] [Related]
18. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799 [TBL] [Abstract][Full Text] [Related]
19. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands. Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Hanson MB; Gallion H; Flanigan RC; Kenady DE Biochemistry; 1985 Dec; 24(27):8101-6. PubMed ID: 4092059 [TBL] [Abstract][Full Text] [Related]